ASPIRING THERAPIES LTD

Company Registration Number:
12554025 (England and Wales)

Unaudited abridged accounts for the year ended 30 April 2022

Period of accounts

Start date: 01 May 2021

End date: 30 April 2022

ASPIRING THERAPIES LTD

Contents of the Financial Statements

for the Period Ended 30 April 2022

Balance sheet
Notes

ASPIRING THERAPIES LTD

Balance sheet

As at 30 April 2022


Notes
2022
13 months to 30 April 2021


£
£
Called up share capital not paid: 0 0
Fixed assets
Intangible assets:   0 0
Tangible assets:   0 0
Investments:   0 0
Total fixed assets: 0 0
Current assets
Stocks: 0 0
Debtors:   0 0
Cash at bank and in hand: 2,342 100
Investments:   0 0
Total current assets: 2,342 100
Creditors: amounts falling due within one year:   0 0
Net current assets (liabilities): 2,342 100
Total assets less current liabilities: 2,342 100
Creditors: amounts falling due after more than one year:   0 0
Provision for liabilities: 0 0
Total net assets (liabilities): 2,342 100
Capital and reserves
Called up share capital: 100 100
Share premium account: 0 0
Revaluation reserve: 00
Other reserves: 0 0
Profit and loss account: 2,242 0
Shareholders funds: 2,342 100

The notes form part of these financial statements

ASPIRING THERAPIES LTD

Balance sheet statements

For the year ending 30 April 2022 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 01 October 2023
and signed on behalf of the board by:

Name: RIAZ SHAKOOR ESSA
Status: Director

The notes form part of these financial statements

ASPIRING THERAPIES LTD

Notes to the Financial Statements

for the Period Ended 30 April 2022

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

ASPIRING THERAPIES LTD

Notes to the Financial Statements

for the Period Ended 30 April 2022

2. Employees

2022 13 months to 30 April 2021
Average number of employees during the period 0 0